E.P.T.Q S500 with Lidocaine 1 x 1.1 ml

Epitique (e.p.t.q.)

Dermal Filler

High-density cross-linked hyaluronic acid filler

CE Marked (CE 2292) dermal filler in the e.p.t.q. S Series for aesthetic use.
Manufactured under the “9 Essentials” purification and quality control process, with endotoxin < 0.1 EU/ml and low residual BDDE.

CE Marked (CE 2292) dermal filler in the e.p.t.q. S Series for aesthetic use.
Manufactured under the “9 Essentials” purification and quality control process, with endotoxin < 0.1 EU/ml and low residual BDDE.

High-density cross-linked hyaluronic acid filler

Description

E.P.T.Q S500 with Lidocaine is a high-density, fully cross-linked hyaluronic acid (HA) dermal filler designed for deep volume restoration, facial contouring and structural augmentation. With a concentration of 24 mg/ml HA and 0.3% lidocaine, the filler offers high viscoelasticity and lift capacity, making it suitable for augmenting cheeks, chin, jawline and correcting severe volume loss. Its highly purified HA formulation is manufactured under the e.p.t.q. “9 Essentials” process to ensure low endotoxin (<0.1 EU/ml) and minimal residual cross-linking agents (BDDE), aiming for safety and durability of results. The product is supplied as a 1.1 ml pre-filled syringe with 27G (or 25G) needle, and must be administered by a licensed practitioner under aseptic conditions.

Bnefits

High-density HA filler provides strong lifting and volume restoration for areas with deep volume loss (cheeks, chin, jawline, mid-face).
Contains 0.3% lidocaine to reduce injection discomfort and increase patient comfort during treatment.
High viscoelasticity and cross-linked, cohesive gel structure allow precise sculpting and stable contouring.
Manufactured under strict purification process (“9 Essentials”) with endotoxin < 0.1 EU/ml and low residual BDDE, reducing risk of inflammation or adverse reactions.
Long-lasting results—effect duration reportedly up to 12–18 months depending on treatment area and patient factors.
CE-marked for safety and compliance with European medical device regulations (where applicable).

Indications

Facial augmentation in areas with volume deficiency (cheeks, mid-face, temples, chin, jawline).
Correction of age-related volume loss and skin sagging / hollowing.
Deep wrinkle and fold correction (e.g. nasolabial folds, marionette lines) when greater lift and volume needed.
Non-surgical contouring procedures such as cheekbone enhancement, chin and jawline definition.
Structural support beneath the skin (supraperiosteal or deep dermal/subcutaneous planes) for significant reshaping or augmentation.